Sign in

CIK 0001706431 · Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812730369
Phone
415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $50.90 ($636,222)
  4. 8-K Event Other events
  5. 4 Open-market sale Chief Business Officer sold 11,110 shares at $47.65 ($529,404)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $47.99 ($379,090)
  9. SC 13D/A Stake Beneficial Ownership Report
  10. 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $48.85 ($385,876)
  11. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $49.53 ($619,118)
  12. 4 Open-market sale CFO sold 30,000 shares at $50.06 ($1,501,731)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 424B4 Offering Prospectus
  16. POS EX Other Post-effective Amendment
  17. EFFECT Other Notice of Effectiveness
  18. S-1MEF Other S-1MEF
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 34 of 41 · 806 filings